Prostatic paracoccidioidomycosis: differential diagnosis of prostate cancer

Mem Inst Oswaldo Cruz. 2009 Feb;104(1):33-6. doi: 10.1590/s0074-02762009000100005.

Abstract

Symptomatic prostatic paracoccidioidomycosis (PCM) is a very rare condition; however, it may express as a typical benign prostatic hyperplasia or a simulating prostatic adenocarcinoma. This case report presents PCM mimicking prostatic adenocarcinoma. The purpose of this paper is to call the general physician's attention to this important differential diagnosis.

Publication types

  • Case Reports

MeSH terms

  • Antiprotozoal Agents / therapeutic use
  • Diagnosis, Differential
  • Humans
  • Itraconazole / therapeutic use
  • Male
  • Middle Aged
  • Paracoccidioides / isolation & purification
  • Paracoccidioidomycosis / diagnosis*
  • Paracoccidioidomycosis / drug therapy
  • Prostate-Specific Antigen / blood
  • Prostatic Hyperplasia / drug therapy
  • Prostatic Hyperplasia / parasitology*
  • Prostatic Neoplasms / diagnosis*
  • Sulfamethoxazole / therapeutic use
  • Trimethoprim / therapeutic use

Substances

  • Antiprotozoal Agents
  • Itraconazole
  • Trimethoprim
  • Prostate-Specific Antigen
  • Sulfamethoxazole